0000000000172697

AUTHOR

Charles Christian Adarkwah

showing 3 related works from this author

Positive Effect of Steroids in Posterior Reversible Encephalopathy Syndrome

2019

We present a case of posterior reversible encephalopathy syndrome with severe clinical manifestation. Apart from initial aphasia, hemiparesis, and a generalized seizure, the patient had a prolonged loss of consciousness. Although blood pressure was normalized, the clinical status deteriorated continuously. After adding steroids to the therapy, the patient recovered rapidly, suggesting that this could have been a useful therapeutic approach. Even the vasogenic edema in the cerebral magnetic resonance imaging disappeared shortly within 6 days.

medicine.medical_specialtyEncephalopathyPATHOPHYSIOLOGYCase ReportEncephalopathylcsh:RC346-42903 medical and health sciencesTherapeutic approach0302 clinical medicineInternal medicineAphasiamedicineMANAGEMENT030212 general & internal medicinelcsh:Neurology. Diseases of the nervous systemSPECTRUMmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingPosterior reversible encephalopathy syndromeEDEMAmedicine.diseaseBlood pressureHemiparesisPosterior reversible encephalopathy syndromeCardiologyEncephalitisNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryEncephalitis
researchProduct

Management of hepatic encephalopathy in Germany: a survey among physicians

2020

 Hepatic encephalopathy (HE) is a severe complication of liver cirrhosis with impairment of quality of life and prognosis. Management patterns among physicians have not been investigated yet. A questionnaire containing 17 questions was sent out to 1468 gastroenterologists and 120 general practitioners (GPs). It included questions regarding diagnostic, therapeutic, and management strategies used in patients with overt HE (OHE) and covert HE (CHE). The response rate was 12 % (n = 172) for gastroenterologists and 45 % (n = 54) for GPs. Of gastroenterologists, 26.7 % examine patients with an initial diagnosis of liver cirrhosis regarding HE. Gastroenterologists favored a combination of differen…

Liver Cirrhosismedicine.medical_specialtyCirrhosisMEDLINEPhysical examinationRifaximin03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGastrointestinal AgentsQuality of lifeGeneral PractitionersGermanySurveys and QuestionnairesSecondary PreventionmedicineHumans030212 general & internal medicinePractice Patterns Physicians'Disease management (health)Hepatic encephalopathyResponse rate (survey)medicine.diagnostic_testbusiness.industryGastroenterologistsGastroenterologyDisease Managementmedicine.diseaseLactuloseRifaximinchemistryHepatic EncephalopathyEmergency medicineQuality of Life030211 gastroenterology & hepatologybusinessZeitschrift für Gastroenterologie
researchProduct

Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study

2020

Bone fractures are a frequent complication in patients with cirrhosis. Proton pump inhibitors (PPIs) are among the most frequently prescribed medications and may impair bone quality and quantity.To investigate whether PPI use predisposes patients with cirrhosis to bone fractures.We performed a population-based case-control study exploring a sample of patients with cirrhosis derived from the Disease Analyzer database. In total, 1795 cirrhotic patients with fractures were compared to 10 235 cirrhotic patients without fractures. PPI use overall and the cumulative PPI dose 5 years prior to the index date were analysed. To estimate the association between PPI use and fractures, logistic regressi…

AdultLiver CirrhosisMalemedicine.medical_specialtyCirrhosisAdolescentPopulationDiseaseLogistic regressionRisk AssessmentFractures BoneYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansPharmacology (medical)030212 general & internal medicineYoung adulteducationAgedAged 80 and overeducation.field_of_studyHepatologybusiness.industryGastroenterologyCase-control studyProton Pump InhibitorsMiddle Agedmedicine.diseaseCase-Control StudiesFemale030211 gastroenterology & hepatologyRisk assessmentbusinessComplicationAlimentary Pharmacology & Therapeutics
researchProduct